SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-025452
Filing Date
2023-07-24
Accepted
2023-07-24 16:04:55
Documents
14
Period of Report
2023-07-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20230724.htm   iXBRL 8-K 33859
2 EX-99.1 csbr8-k4302023exhibit991.htm EX-99.1 176191
6 GRAPHIC fy2016pr_image1a20a.jpg GRAPHIC 24002
  Complete submission text file 0001628280-23-025452.txt   370284

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20230724.xsd EX-101.SCH 1932
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20230724_lab.xml EX-101.LAB 21065
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20230724_pre.xml EX-101.PRE 10996
8 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20230724_htm.xml XML 2446
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 231105084
SIC: 2836 Biological Products, (No Diagnostic Substances)